140 related articles for article (PubMed ID: 30868533)
1. Analytics of Functional Autoantibodies in Patients with Chagas Disease.
Wallukat G; Wenzel K; Schimke I
Methods Mol Biol; 2019; 1955():247-261. PubMed ID: 30868533
[TBL] [Abstract][Full Text] [Related]
2. Functional autoantibody diseases: Basics and treatment related to cardiomyopathies.
Becker NP; Goettel P; Mueller J; Wallukat G; Schimke I
Front Biosci (Landmark Ed); 2019 Jan; 24(1):48-95. PubMed ID: 30468647
[TBL] [Abstract][Full Text] [Related]
3. Aptamer BC007 for neutralization of pathogenic autoantibodies directed against G-protein coupled receptors: A vision of future treatment of patients with cardiomyopathies and positivity for those autoantibodies.
Wallukat G; Müller J; Haberland A; Berg S; Schulz A; Freyse EJ; Vetter R; Salzsieder E; Kreutz R; Schimke I
Atherosclerosis; 2016 Jan; 244():44-7. PubMed ID: 26584137
[TBL] [Abstract][Full Text] [Related]
4. Distinct patterns of autoantibodies against G-protein-coupled receptors in Chagas' cardiomyopathy and megacolon. Their potential impact for early risk assessment in asymptomatic Chagas' patients.
Wallukat G; Muñoz Saravia SG; Haberland A; Bartel S; Araujo R; Valda G; Duchen D; Diaz Ramirez I; Borges AC; Schimke I
J Am Coll Cardiol; 2010 Feb; 55(5):463-8. PubMed ID: 20117461
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies directed against α1-adrenergic receptor and endothelin receptor A in patients with prostate cancer.
Wallukat G; Jandrig B; Becker NP; Wendler JJ; Göttel P; Müller J; Schostak M; Schimke I
Auto Immun Highlights; 2020 Sep; 11(1):13. PubMed ID: 32977857
[TBL] [Abstract][Full Text] [Related]
6. Agonistic Autoantibodies to the β2-Adrenergic Receptor Involved in the Pathogenesis of Open-Angle Glaucoma.
Jünemann A; Hohberger B; Rech J; Sheriff A; Fu Q; Schlötzer-Schrehardt U; Voll RE; Bartel S; Kalbacher H; Hoebeke J; Rejdak R; Horn F; Wallukat G; Kunze R; Herrmann M
Front Immunol; 2018; 9():145. PubMed ID: 29483909
[TBL] [Abstract][Full Text] [Related]
7. Cardiomyopathy - An approach to the autoimmune background.
Becker NP; Müller J; Göttel P; Wallukat G; Schimke I
Autoimmun Rev; 2017 Mar; 16(3):269-286. PubMed ID: 28163240
[TBL] [Abstract][Full Text] [Related]
8. Doberman pinschers present autoimmunity associated with functional autoantibodies: A model to study the autoimmune background of human dilated cardiomyopathy.
Wess G; Wallukat G; Fritscher A; Becker NP; Wenzel K; Müller J; Schimke I
PLoS One; 2019; 14(7):e0214263. PubMed ID: 31276517
[TBL] [Abstract][Full Text] [Related]
9. Spontaneously beating neonatal rat heart myocyte culture-a model to characterize angiotensin II at(1) receptor autoantibodies in patients with preeclampsia.
Wallukat G; Nissen E; Neichel D; Harris J
In Vitro Cell Dev Biol Anim; 2002; 38(7):376-7. PubMed ID: 12534336
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies Directed Against the Endothelin A Receptor in Patients With Benign Prostatic Hyperplasia.
Wallukat G; Jandrig B; Kunze R; Wendler JJ; Müller J; Schostak M; Schimke I
Prostate; 2017 Apr; 77(5):458-465. PubMed ID: 27882567
[TBL] [Abstract][Full Text] [Related]
11. Difference between beta1-adrenoceptor autoantibodies of human and animal origin-Limitations detecting beta1-adrenoceptor autoantibodies using peptide based ELISA technology.
Wenzel K; Schulze-Rothe S; Müller J; Wallukat G; Haberland A
PLoS One; 2018; 13(2):e0192615. PubMed ID: 29425252
[TBL] [Abstract][Full Text] [Related]
12. Structural and functional analysis of the B cell epitopes recognized by anti-receptor autoantibodies in patients with Chagas' disease.
Elies R; Ferrari I; Wallukat G; Lebesgue D; Chiale P; Elizari M; Rosenbaum M; Hoebeke J; Levin MJ
J Immunol; 1996 Nov; 157(9):4203-11. PubMed ID: 8892658
[TBL] [Abstract][Full Text] [Related]
13. Aptamer neutralization of beta1-adrenoceptor autoantibodies isolated from patients with cardiomyopathies.
Haberland A; Wallukat G; Dahmen C; Kage A; Schimke I
Circ Res; 2011 Oct; 109(9):986-92. PubMed ID: 21868696
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies in Serum of Systemic Scleroderma Patients: Peptide-Based Epitope Mapping Indicates Increased Binding to Cytoplasmic Domains of CXCR3.
Recke A; Regensburger AK; Weigold F; Müller A; Heidecke H; Marschner G; Hammers CM; Ludwig RJ; Riemekasten G
Front Immunol; 2018; 9():428. PubMed ID: 29623076
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies Specifically Against β1 Adrenergic Receptors and Adverse Clinical Outcome in Patients With Chronic Systolic Heart Failure in the β-Blocker Era: The Importance of Immunoglobulin G3 Subclass.
Nagatomo Y; Li D; Kirsop J; Borowski A; Thakur A; Tang WH
J Card Fail; 2016 Jun; 22(6):417-22. PubMed ID: 26997620
[TBL] [Abstract][Full Text] [Related]
16. Agonistic autoantibodies directed against G-protein-coupled receptors and their relationship to cardiovascular diseases.
Wallukat G; Schimke I
Semin Immunopathol; 2014 May; 36(3):351-63. PubMed ID: 24777744
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies against the beta1 adrenoceptor from patients with dilated cardiomyopathy prolong action potential duration and enhance contractility in isolated cardiomyocytes.
Christ T; Wettwer E; Dobrev D; Adolph E; Knaut M; Wallukat G; Ravens U
J Mol Cell Cardiol; 2001 Aug; 33(8):1515-25. PubMed ID: 11448139
[TBL] [Abstract][Full Text] [Related]
18. Aptamer BC 007 - A broad spectrum neutralizer of pathogenic autoantibodies against G-protein-coupled receptors.
Haberland A; Holtzhauer M; Schlichtiger A; Bartel S; Schimke I; Müller J; Dandel M; Luppa PB; Wallukat G
Eur J Pharmacol; 2016 Oct; 789():37-45. PubMed ID: 27375076
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies against the β3-adrenoceptor protect from cardiac dysfunction in a rat model of pressure overload.
Wang J; Li M; Ma X; Bai K; Wang L; Yan Z; Lv T; Zhao Z; Zhao R; Liu H
PLoS One; 2013; 8(10):e78207. PubMed ID: 24147120
[TBL] [Abstract][Full Text] [Related]
20. GPCR-specific autoantibody signatures are associated with physiological and pathological immune homeostasis.
Cabral-Marques O; Marques A; Giil LM; De Vito R; Rademacher J; Günther J; Lange T; Humrich JY; Klapa S; Schinke S; Schimke LF; Marschner G; Pitann S; Adler S; Dechend R; Müller DN; Braicu I; Sehouli J; Schulze-Forster K; Trippel T; Scheibenbogen C; Staff A; Mertens PR; Löbel M; Mastroianni J; Plattfaut C; Gieseler F; Dragun D; Engelhardt BE; Fernandez-Cabezudo MJ; Ochs HD; Al-Ramadi BK; Lamprecht P; Mueller A; Heidecke H; Riemekasten G
Nat Commun; 2018 Dec; 9(1):5224. PubMed ID: 30523250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
